Gainey McKenna & Egleston Announces They Have Filed A Class Action...

Gainey McKenna & Egleston Announces They Have Filed A Class Action...

Gainey McKenna & Egleston announces that they have filed a class action lawsuit on behalf of their client against BioCryst Pharmaceuticals, Inc. in the United States District Court for the District of Delaware on behalf of current common stock holders of BioCryst, seeking to pursue remedies under the Securities Exchange Act of 1934 . On January 21, 2018, BioCryst and Idera Pharmaceuticals, Inc. , Nautilus Holdco, Inc., a direct, wholly owned subsidiary of BCRX , Island Merger Sub, Inc., a direct, wholly owned subsidiary of Holdco , and Boat Merger Sub, Inc., a direct, wholly owned subsidiary of Holdco , entered into an Agreement and Plan of Merger .

from Biotech News